ITP Drug Disappoints in Hospitalized COVID Patients With Hypoxemia

(MedPage Today) -- The spleen tyrosine kinase inhibitor fostamatinib (Tavalisse) did not improve outcomes in adults hospitalized with COVID-19 and hypoxemia, a phase III randomized trial showed.
Among 400 patients, the mean number of oxygen-free...